PBC Dermatology

PBC Dermatology is a healthcare provider specializing in comprehensive dermatological care, offering both medical and cosmetic services tailored to individual patient needs. The company is known for its collaborative approach to skin health. Founded in West Palm Beach, US, PBC Dermatology focuses on delivering specialized dermatological services. In May 2019, Water's Edge Dermatology, Inc.

, acquired a controlling stake in PBC Dermatology, enhancing its operational capacity. Specific details of the transaction were not disclosed. PBC Dermatology specializes in comprehensive dermatological care, offering both medical and cosmetic dermatology services. Core offerings include treatments for various skin conditions, skin cancer education, and non-surgical skin rejuvenation techniques.

The company emphasizes a patient-centered model, ensuring collaboration among healthcare providers to address individual skin care concerns effectively. Primarily serving patients in Central Florida, PBC also attracts clients from surrounding regions seeking specialized dermatological care. The practice is recognized for its conservative approach to cosmetic procedures, enabling patients to achieve natural-looking results that enhance their confidence. PBC Dermatology generates revenue through direct patient interactions, with services billed based on specific treatments provided.

Their revenue model includes fee-for-service arrangements, allowing patients to pay for individual consultations and treatments, including medical evaluations and cosmetic procedures. Patients can opt for one-time transactions or enroll in ongoing care plans for chronic skin conditions requiring regular monitoring. Pricing structures are established based on treatment nature and complexity, ensuring transparency regarding healthcare expenditures. PBC Dermatology plans to leverage its recent acquisition by Water's Edge Dermatology, Inc.

to enhance its service offerings and expand into additional markets. The company aims to explore new product lines and potentially increase its geographic reach beyond Central Florida by 2022. Additionally, the strategic support from the acquisition will facilitate the development and launch of new dermatological treatments, catering to an evolving patient demographic.